高効率のCRISPRノックインは,TCF1がT細胞枯渇を逆転させるのに不十分であることを示しています
Maria N de Menezes1,2, Amanda X Y Chen3,4, Nihali Kulkarni3
1Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, 3000, Victoria, Australia. maria.nogueirademenezes@petermac.org.
Nature communications
|February 17, 2026
まとめ
転写因子TCF1は,幹細胞のようなCD8+T細胞を維持するために重要である. しかし,過剰発現するTCF1は,終末期に枯渇したT細胞を幹細胞のような状態に戻すことはできず,その治療的可能性を制限します.
科学分野:
- 免疫学 免疫学とは
- 細胞生物学 細胞生物学
- がん研究 がん研究
背景:
- CD8+T細胞の枯渇は,慢性的な抗原刺激から生じ,がん免疫と持続的な感染症に影響を及ぼします.
- 幹細胞のような枯渇したT細胞サブセットは,免疫療法の有効性にとって重要である.
- TCF1は,これらの幹のような集団の形成と維持に不可欠です.
研究 の 目的:
- TCF1が,終末期に枯渇したT細胞を,幹細胞のような状態に積極的に分化できるかどうかを調査する.
- 構成的または条件的TCF1過剰発現のためにT細胞を設計する in vivo.
主な方法:
- 高効率のCRISPRノックイン方法論を最適化しました.
- T細胞枯渇のインビボマウスモデル.
- エンジニアリングT細胞は,TCF1を構成的または条件的に過剰に発現させる.
主要な成果:
- 構成的なTCF1過剰発現は,幹細胞のようなT細胞プールサイズを増加させた.
- 中途半端に枯渇した細胞における条件付きTCF1過剰発現は,それらの細胞を幹細胞のような状態に戻さなかった.
- TCF1は分化を遅らせるようだが,末端疲労を逆転させることはできない.
結論:
- TCF1は,幹細胞のようなT細胞のさらなる分化を防止する役割を果たします.
- TCF1は,すでに末期的に枯渇したT細胞を区別するのに不十分です.
- 発見は,確立されたT細胞枯渇を逆転させるためのTCF1ベースの戦略の限界を示唆しています.
関連する概念動画
CRISPR
Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced Short...
CRISPR and crRNAs
Bacteria and archaea are susceptible to viral infections just like eukaryotes; therefore, they have developed a unique adaptive immune system to protect themselves. Clustered regularly interspaced short palindromic repeats and CRISPR-associated proteins (CRISPR-Cas) are present in more than 45% of known bacteria and 90% of known archaea.
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
CRISPR
Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced Short...
CRISPR/Cas9 Genome Editing
The CRISPR-Cas system serves as a bacterial defense mechanism against invading genetic elements such as viruses and plasmids, forming the foundation for its adaptation as a powerful genome-editing tool. Originally discovered in prokaryotes, this system has been repurposed to revolutionize genetic engineering across a wide range of organisms, including plants, animals, and humans. The core component, Cas9, is an endonuclease derived from Streptococcus pyogenes, capable of introducing...


